Globeflex Capital L P lowered its position in Icon Plc (NASDAQ:ICLR) by 2.8% in the third quarter, HoldingsChannel.com reports. The firm owned 172,522 shares of the medical research company’s stock after selling 4,901 shares during the quarter. Icon makes up about 5.2% of Globeflex Capital L P’s holdings, making the stock its largest position. Globeflex Capital L P’s holdings in Icon were worth $26,525,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in ICLR. WCM Investment Management CA lifted its position in shares of Icon by 7.9% during the 3rd quarter. WCM Investment Management CA now owns 5,000,711 shares of the medical research company’s stock valued at $768,860,000 after acquiring an additional 367,131 shares during the period. Acadian Asset Management LLC raised its position in shares of Icon by 0.4% during the 3rd quarter. Acadian Asset Management LLC now owns 2,181,795 shares of the medical research company’s stock worth $335,450,000 after purchasing an additional 8,880 shares during the last quarter. Renaissance Technologies LLC raised its position in shares of Icon by 0.6% during the 2nd quarter. Renaissance Technologies LLC now owns 1,933,360 shares of the medical research company’s stock worth $256,228,000 after purchasing an additional 10,600 shares during the last quarter. Boston Partners raised its position in shares of Icon by 2.4% during the 2nd quarter. Boston Partners now owns 1,665,259 shares of the medical research company’s stock worth $220,696,000 after purchasing an additional 38,819 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA raised its position in shares of Icon by 12.9% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,070,319 shares of the medical research company’s stock worth $164,561,000 after purchasing an additional 121,970 shares during the last quarter. Hedge funds and other institutional investors own 85.09% of the company’s stock.

Several research analysts recently issued reports on ICLR shares. BidaskClub upgraded Icon from a “hold” rating to a “buy” rating in a research report on Wednesday, September 5th. Evercore ISI upgraded Icon from an “in-line” rating to an “outperform” rating in a research report on Friday, October 26th. Zacks Investment Research upgraded Icon from a “hold” rating to a “buy” rating and set a $163.00 price objective for the company in a research report on Thursday, August 9th. Robert W. Baird lifted their price objective on Icon from $154.00 to $157.00 and gave the stock an “outperform” rating in a research report on Tuesday, September 11th. Finally, UBS Group started coverage on Icon in a research report on Tuesday, October 9th. They set a “sell” rating and a $145.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and eight have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $148.00.

Shares of Icon stock opened at $128.27 on Wednesday. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.17 and a quick ratio of 2.17. Icon Plc has a 1 year low of $101.22 and a 1 year high of $155.33. The company has a market cap of $6.92 billion, a P/E ratio of 23.80, a P/E/G ratio of 1.84 and a beta of 0.50.

Icon (NASDAQ:ICLR) last issued its quarterly earnings data on Wednesday, October 24th. The medical research company reported $1.54 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.54. The firm had revenue of $655.02 million during the quarter, compared to the consensus estimate of $654.66 million. Icon had a return on equity of 26.08% and a net margin of 12.88%. On average, analysts forecast that Icon Plc will post 6.08 EPS for the current fiscal year.

WARNING: “Icon Plc (ICLR) is Globeflex Capital L P’s Largest Position” was posted by Daily Political and is the property of of Daily Political. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright laws. The correct version of this article can be read at https://www.dailypolitical.com/2018/11/21/icon-plc-iclr-is-globeflex-capital-l-ps-largest-position.html.

Icon Company Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. It specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.

See Also: How Important is Technical Analysis of Stocks

Want to see what other hedge funds are holding ICLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Icon Plc (NASDAQ:ICLR).

Institutional Ownership by Quarter for Icon (NASDAQ:ICLR)

Receive News & Ratings for Icon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon and related companies with MarketBeat.com's FREE daily email newsletter.